Daniel W Bowles

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Squamous Cell Carcinoma

Metastatic Colorectal Cancer

Vascular Endothelial Growth Factor

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Ilana M Braun, Kari Bohlke, Donald I Abrams, Holly Anderson, Nicholas G Zaorsky, Lynda G Balneaves, Daniel W Bowles, Peter Ray Chai, Anuja Damani, Arjun Gupta, Sigrun Hallmeyer, Ishwaria M Subbiah, Chris Twelves, Mark S Wallace, Eric J Roeland
Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Rona Yaeger, Meredith A McKean, Rizwan Haq, J Thaddeus Beck, Matthew H Taylor, Jonathan Eliezer Cohen, Daniel W Bowles, Shirish M Gadgeel, Catalin Mihalcioiu, Kyriakos P Papadopoulos, Eli L Diamond, Keren B Sturtz, Gang Feng, Stefanie K Drescher, Micaela B Reddy, Bhaswati Sengupta, Arnab Kumar Maity, Suzy A Brown, Anurag Singh, Eric N Brown, Brian R Baer, Jim Wong, Tung-Chung Mou, Wen-I Wu, Dean R Kahn, Sunyana Gadal, Neal X Rosen, John J Gaudino, Patrice A Lee, Dylan P Hartley, S Michael Rothenberg
A next-generation BRAF inhibitor overcomes resistance to BRAF inhibition in patients with BRAF-mutant cancers using pharmacokinetics-informed dose escalation. Cancer discovery (2024)
Jena D French, Bryan R Haugen, Francis P Worden, Daniel W Bowles, Andrew G Gianoukakis, Bhavana Konda, Ramona Dadu, Eric J Sherman, Shaylene McCue, Nathan R Foster, Yuri E Nikiforov, Ticiana Della Justina Farias, Paul J Norman, Lori J Wirth
Combination Targeted Therapy with Lenvatinib and Pembrolizumab in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Jena D French, Bryan R Haugen, Francis P Worden, Daniel W Bowles, Andrew G Gianoukakis, Bhavana Konda, Ramona Dadu, Eric J Sherman, Shaylene McCue, Nathan R Foster, Yuri E Nikiforov, Ticiana Della Justina Farias, Paul J Norman, Lori J Wirth
Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Ilana M Braun, Kari Bohlke, Donald I Abrams, Holly Anderson, Nicholas G Zaorsky, Lynda G Balneaves, Daniel W Bowles, Peter Ray Chai, Anuja Damani, Arjun Gupta, Sigrun Hallmeyer, Ishwaria M Subbiah, Chris Twelves, Mark S Wallace, Eric J Roeland
Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Alice N Weaver, Stephanie Lakritz, Divneet Mandair, Mark B Ulanja, Daniel W Bowles
A molecular guide to systemic therapy in salivary gland carcinoma. Head & neck (2023)
Glenn J Hanna, Myung-Ju Ahn, Jameel Muzaffar, Bhumsuk Keam, Daniel W Bowles, Deborah J Wong, Alan L Ho, Sung-Bae Kim, Francis P Worden, Tak Yun, Xianzhang Meng, Jan M Van Tornout, Maureen G Conlan, Hyunseok Kang
A Phase 2 Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Alan L Ho, Nathan R Foster, Alex J Zoroufy, Jordan D Campbell, Francis Worden, Katharine Price, Douglas R Adkins, Daniel W Bowles, Hyunseok Kang, Barbara A Burtness, Eric J Sherman, Roscoe Morton, Luc G T Morris, Zaineb Nadeem, Nora Katabi, Pamela N Munster, Gary K Schwartz
Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)